Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Paul Singer Launches Latest Activist Campaign, While Eminence Capital Buys More Shares of a Favorite Stock

Page 1 of 2

Hedge funds and other money managers have now filed their quarterly 13Fs for the September quarter, so one can investigate these public filings in order to find potential winners. However, there are some who believe the fact that these public filings are “delayed” means they are not informative (although our research has proven otherwise). Therefore, the camp of ‘13F skeptics’ can follow hedge funds’ 13G and 13D filings instead, which are submitted in a more timely manner and may offer more insights about investors’ stances on different companies. In fact, extensive research has shown that activist targets tend to outperform stock market benchmarks and generate attractive returns uncorrelated with the broader market. With this in mind, the following article will discuss two 13D filings submitted with the SEC by two reputable hedge funds monitored by Insider Monkey.


Following activist funds is important because it is a very specific and focused strategy in which the investor doesn’t have to wait for catalysts to realize gains in the holding. An activist fund can simply create its own catalysts by pushing for them through negotiations with the company’s management and directors. In recent years, the average returns of activists’ hedge funds has been much higher than the returns of an average hedge fund. Furthermore, we believe do-it-yourself investors have an advantage over activist hedge fund investors because they don’t have to pay 2% of their assets and 20% of their gains every year to compensate hedge fund managers. We have found through extensive research that the top small-cap picks of hedge funds are also capable of generating high returns and built a system around this premise. In the 38 months since our small-cap strategy was launched it has returned 102% and beaten the S&P 500 ETF (SPY) by more than 53 percentage points (read more details).

According to a freshly-filed 13D with the SEC, Paul Singer’s Elliott Associates L.P. and its affiliates have combined economic exposure in American Capital Ltd. (NASDAQ:ACAS) of roughly 8.4% of its outstanding common stock. Paul Singer’s activist hedge fund owns 12.23 million shares of common stock, but also holds cash-settled equity swaps with respect to 9.88 million shares. On November 16, Elliott sent a letter to American Capital’s Board of Directors, outlining its disapproval with the company’s intentions to spin out its BDC assets into a new business development company. Singer and his team believe that this move “will put valuable assets at risk, serve to entrench management and significantly limit options for future stockholder value creation”.

Let us remind you that American Capital Ltd. (NASDAQ:ACAS)’s Board decided to split its BDC segment from its funds-management business back in 2014 by spinning-off two business development companies. However, the Board recently revised its plan and decided to concentrate capital in one BDC only. The new BDC would eventually be aimed at expanding the company’s Sponsor Finance business into leading and syndicating large middle market transactions (i.e. unitranche, second lien and mezzanine lending). Going back to the recently-filed 13D, Elliott reckons that the private equity and venture capital firm’s portfolio “could support a share price in excess of $23.00”, which yields an upside of at least 32%. The activist hedge fund also released a presentation that outlines its views on the company’s potential and its ‘destructive’ spin-off in greater detail, but also presents a five-step plan to create greater shareholder value.

Paul Singer
Paul Singer
Elliott Management

In the meantime, the number of hedge funds tracked by Insider Monkey with positions in the private equity and venture capital firm stood at 38 at the end of the second quarter, compared to 33 registered in the prior one. Even so, the value of their investments decreased quarter-over-quarter to $1.27 billion from $1.38 billion. These money managers amassed 34.00% of the company’s outstanding common stock on June 30. Fir Tree, founded by Jeffrey Tannenbaum reported owning 12.05 million shares in American Capital Ltd. (NASDAQ:ACAS) during the latest round of 13F filings.

Follow American Capital Ltd (NASDAQ:ACAS)
Trade (NASDAQ:ACAS) Now!

Let’s head to the next page of the article, where we discuss Eminence Capital’s activist target.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!